Dr. Jain is a consultant in neurology and has no relevant financial relationships to disclose.)
Historical note and terminology
Citalopram is a selective serotonin-reuptake inhibitor. Serotonin, or 5-hydroxytryptamine, was discovered in 1948 (Rapport et al 1948), and since then has played an increasing part in the understanding of human diseases, particularly those involving the nervous system. Fluoxetine, the first drug of this category, was introduced in 1988, and citalopram came a decade later. Escitalopram, the therapeutically active (S)-enantiomer of citalopram, as an improved follow-up compound for the potential treatment of depression, was approved in 2002.
The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.
If you are a subscriber, please log in.
If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.